Publications by authors named "Elise Toussaint"

Article Synopsis
  • The study investigates the role of the cerebellum-to-liver uptake ratio (CLIP) as a prognostic factor for patients with post-transplant lymphoproliferative disorders (PTLD), in addition to the International Prognostic Index (IPI) score.
  • A total of 97 PTLD patients were analyzed, revealing that both a higher IPI score (≥ 3) and lower CLIP (< 3.24) correlated with poorer progression-free survival (PFS) outcomes.
  • While CLIP shows potential as a predictor for PFS, its association with overall survival (OS) was not statistically significant, indicating that further research is needed to validate these findings.
View Article and Find Full Text PDF

Estradiol and estrogen receptor α (ERα) have been shown to be important for the maintenance of skeletal muscle strength in females; however, little is known about the roles of estradiol and ERα in male muscle. The purpose of this study was to determine if skeletal muscle ERα is required for optimal contractility in male mice. We hypothesize that reduced ERα in skeletal muscle impairs contractility in male mice.

View Article and Find Full Text PDF
Article Synopsis
  • Histologic transformation (HT) to diffuse large B-cell lymphoma is rare in Waldenström macroglobulinemia, particularly in patients who have the MYD88 wild-type gene.
  • Clinically, HT is indicated by symptoms like rapidly growing lymph nodes, high lactate dehydrogenase levels, or signs of disease outside of lymph nodes, and requires a histologic examination for diagnosis.
  • HT has a worse prognosis than nontransformed Waldenström macroglobulinemia and is often treated with chemoimmunotherapy (like R-CHOP), with CNS prophylaxis and potential autologous transplant for suitable patients being additional considerations.
View Article and Find Full Text PDF

Post-transplant lymphoproliferative disorder (PTLD) is a rare complication of immunosuppression. Sequential treatment is commonly proposed, combining induction with rituximab (R-induction) followed by either continuation of treatment or addition of chemotherapy depending on response. Response to R-induction, often assessed by CT scan, is a major predictor of overall survival (OS).

View Article and Find Full Text PDF

In symptomatic Waldenström macroglobulinemia (sWM) patients, prognosis is assessed with the international prognostic scoring system (IPSSWM). In follicular lymphoma and other B-cell and T-cell lymphomas, disease progression within 24 months (POD24) or (in patients without POD24) after 24 months has been proposed as the start date for stratifying subsequent survival. In the present report, we assessed in a large series of 472 sWM patients, the prognostic value of this new dynamic endpoint already reported in many other lymphomas subtypes.

View Article and Find Full Text PDF

Ecosystem functions are driven by abiotic and biotic factors, but due to high collinearity of both, it is often difficult to disentangle the drivers of these ecosystem functions. We studied sedimentological and faunal controls of benthic organic matter mineralization, a crucial ecosystem process provided for by sediments of shelf seas. Subtidal benthic habitats representative of the wide permeability gradient found in the Belgian Part of the North Sea (Northeast Atlantic Shelf) were characterized in terms of sediment descriptors, macrofauna, and sediment biogeochemistry was estimated.

View Article and Find Full Text PDF

Histological transformation into diffuse large B-cell lymphoma is a rare complication in patients with Waldenström macroglobulinemia (WM) usually associated with a poor prognosis. The objective of this study was to develop and validate a prognostic index for survival in transformed WM patients. Through this multicenter, international collaborative effort, we developed a scoring system based on data from 133 patients with transformed WM who were evaluated between 1995 and 2016 (training cohort).

View Article and Find Full Text PDF

A chronic antigenic stimulation is believed to sustain the leukemogenic development of chronic lymphocytic leukemia (CLL) and most of lymphoproliferative malignancies developed from mature B cells. Reproducing a proliferative stimulation ex vivo is critical to decipher the mechanisms of leukemogenesis in these malignancies. However, functional studies of CLL cells remains limited since current ex vivo B cell receptor (BCR) stimulation protocols are not sufficient to induce the proliferation of these cells, pointing out the need of mandatory BCR co-factors in this process.

View Article and Find Full Text PDF
Article Synopsis
  • - Ruxolitinib is a medication used to treat conditions like polycythemia vera and myelofibrosis by inhibiting JAK-1 and JAK-2 enzymes.
  • - In the initial pivotal trials, only one out of 485 patients developed tuberculosis while taking ruxolitinib, but subsequent reports have noted a total of 14 cases.
  • - In a study of 65 patients treated with ruxolitinib, 3% experienced mycobacterial infections, indicating a potentially higher risk than in earlier trials and highlighting the possibility of atypical infections.
View Article and Find Full Text PDF

Invasive pulmonary aspergillosis (IPA) is a common complication of immunosuppression. Rapid diagnosis using molecular techniques is essential to improve patient survival. PCR techniques are promising in enhancing Aspergillus detection in blood and respiratory samples.

View Article and Find Full Text PDF
Article Synopsis
  • * Most patients (91%) exhibit extranodal involvement, often affecting the central nervous system, skin, or testicles, and the majority of cases analyzed showed a non-germinal center B-cell phenotype.
  • * First-line treatment typically involves an R-CHOP regimen, achieving a 61% response rate, but the overall survival after transformation is only 16 months, with worse outcomes linked to delayed transformation and elevated LDH levels.
View Article and Find Full Text PDF

Recently, several randomized studies have been published that will shape treatment decisions in the prevention and management of invasive mould infections. Liposomal amphotericin B is an option for empirical or targeted treatment of invasive aspergillosis or mucormycosis, but for prophylaxis therapy, the triazole class now predominates. The triazole voriconazole is currently regarded as a drug of choice for the treatment of proven or probable invasive aspergillosis, and has shown significantly higher response rates than amphotericin B deoxycholate in this setting, with fewer severe drug-related adverse events.

View Article and Find Full Text PDF